"Mutations in the HUWE1 gene cause a severe neurodevelopmental syndrome," says Dr. Lehrbach. Furthermore, "HUWE1 is often highly expressed and/or mutated in cancer."
He continues, "The underlying reasons why HUWE1 mutations severely affect the nervous system and impact tumorigenesis are not well understood. There are no treatments for the HUWE1 syndrome."
Knockout of eel-1 in wild-type C. elegans did not lead to detectable GFP accumulation. However, combining eel-1 knockout with perturbations of other known proteasome components led to GFP pileup and severe developmental and physiological defects in the worms.
The authors went further: they restored EEL-1 expression, but with mutations in its ubiquitin-binding domains that are homologous to disease alleles in humans with HUWE1-related disorders. These worms also showed severe defects akin to eel-1 knockout, indicating that the ubiquitin ligase activity of the EEL-1 protein is critical for its role in maintaining the UPS.
One striking feature of EEL-1, and other ubiquitin ligases, is the presence of lysine deserts, which are long stretches of amino acids that contain absolutely no lysine residues.
Lysine deserts are thought to be important for regulation of UPS components. Ubiquitin ligases target lysines specifically; therefore, any nearby lysine residues of the ubiquitin ligase itself could lead to auto-ubiquitination and degradation of the ligase instead of the target protein.
To test this hypothesis, the authors engineered lysines into and adjacent to the lysine deserts of EEL-1. They found that, indeed, lysine residues around these critical regions impair EEL-1 stability and ability to ubiquitinate its substrates.
"Our genetic analysis in the worm shows that EEL-1/HUWE1 plays a general role in promoting efficient degradation of ubiquitinated proteins during animal development," says Dr. Lehrbach. "These insights from worm genetics provide a new way to think about HUWE1 functions in human health and disease."
"It suggests," he adds, "that inefficient protein degradation may be an underlying cause of neurodevelopmental symptoms in HUWE1 patients, or the role of HUWE1 in cancer."
In future work, the lab is interested in untangling the complex knot of redundancy in UPS components. HUWE1 is just one of several ubiquitin ligases that promotes efficient protein degradation, and there are many others that could act in tandem in different contexts.
"We are interested in the possibility that a system made up by HUWE1 and other ubiquitin ligases provides animal cells with a versatile way to adapt protein degradation to different types of physiological or environmental stress," Dr. Lehrbach explains. "This is an idea we are actively following up on now."
Additionally, they are interested in whether HUWE1 activity could be enhanced somehow, with the goal of preventing neurodegenerative diseases or enhancing lifespan. The worm's short life makes it ideal for this kind of question, as Dr. Lehrbach explains.
"The worm is a fantastic model to explore the role of HUWE1 in aging,” he says. “Because of its rapid life cycle, experiments that test changes in aging caused by different mutations or drugs can be completed in 3-4 weeks.
“The same experiment in a mouse model would take years!” he emphasizes.
Their system is an impressive and useful model when it comes to detangling our complex system of controlled cellular destruction, and their results could shed light on how to treat diseases caused by the UPS gone haywire.